Description: Manhattan Scientifics, Inc. operates as a technology incubator that seeks to acquire, develop and commercialize technologies in various fields, with emphasis in the areas of nanotechnology. The Company is focused on technology transfer and commercialization of transformative technologies in the nano medicine space. The Company has two subsidiaries, both focused on nanotechnology applications in medicine: Metallicum, Inc. and Senior Scientific LLC. The Company's bioimaging and nanomagnetic detection systems have been developed to detect cancer and other diseases earlier and with specificity. It has developed hardware and software for the sensitive detection of nanomagnetic particles that can be linked to antibodies for the detection and treatment of cancer and other human diseases, all without the use of ionizing radiation or large magnetic fields. Its technologies make possible the earlier detection of cancer in vivo, and the ability to analyze biopsies with sensitivity.
Home Page: www.mhtx.com
244 Fifth Avenue
New York,
NY
10001
United States
Phone:
212 541 2405
Officers
| Name | Title |
|---|---|
| Mr. Marvin Maslow | Founder & Chairman |
| Mr. Emmanuel Tsoupanarias | Pres, CEO & Director |
| Mr. Leonard C. Friedman | Sec. |
| Mr. Robert Romeo Proulx | Pres of Imagion |
Exchange: OTCQB
Country: US
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: | Biotechnology |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 15.6397 |
| Price-to-Sales TTM: | 99.552 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 1 |